Virtual Summit: Current Treatments for GPA and MPA Including the Recently FDA-approved Avacopan

Join Dr. Peter Merkel and Dr. Tanaz Kermani for a discussion about current treatments for GPA And MPA, including the recently FDA-approved drug, avacopan.  Dr. Merkel will give an overview of the medications and then Dr. Kermani will moderate a Q&A session with the attendees.

After the first session we will convene a panel of expert patients, Art Diaz, Jenn Gordon and Kathy Olevsky to discuss “Talking to Your Doctor About Changing Treatments.”

The summit will be recorded and available for viewing after post-production work.

Peter A. Merkel, MD, MPH, Chief, Division of Rheumatology, Professor of Medicine, University of Pennsylvania
Tanaz A. Kermani, MD, Founder and Director of the Vasculitis Program, UCLA
Patient-Expert Panelists:  Art Diaz, GPA,  Jenn Gordon, PhD, EGPA, and Kathy Olevsky, MPA

Register in advance for this virtual webinar on the Zoom platform:

Saturday, March 26, 2022
10:00 a.m. – 11:00 a.m. Central Time